[
    {
        "file_name": "cnspharmaceuticalsinc_20200326_8-k_ex-10.1_12079626_ex-10.1_development agreement.pdf",
        "perturbation": [
            {
                "type": "Inconsistencies - Legal Contradiction",
                "original_text": "within thirty Business Days from the date of this Agreement, CNS will make an upfront payment of $225,000 to WPD",
                "changed_text": "within ninety Business Days from the date of this Agreement, CNS will make an upfront payment of $225,000 to WPD",
                "explanation": "This change extends the payment deadline to 90 business days. Many jurisdictions have prompt payment laws requiring payments to be made within a shorter timeframe, often 30-60 days. Delaying the payment to 90 business days can violate such regulations, potentially leading to penalties or legal action for late payment.",
                "contradicted_law": "Prompt Payment Laws (Vary by State/Jurisdiction)",
                "location": "2.1"
            },
            {
                "type": "Inconsistencies - Legal Contradiction",
                "original_text": "Thereafter, WPD shall furnish to CNS Development Fees no later than forty-five days after the end of each Calendar Quarter for the Sale of Development Products through the end of such Calendar Quarter and shall further furnish CNS with a written statement setting forth an accounting showing the calculation of the Development Fees.",
                "changed_text": "Thereafter, WPD shall furnish to CNS Development Fees no later than ninety days after the end of each Calendar Quarter for the Sale of Development Products through the end of such Calendar Quarter and shall further furnish CNS with a written statement setting forth an accounting showing the calculation of the Development Fees.",
                "explanation": "Extending the deadline for furnishing Development Fees to 90 days could conflict with standard commercial practices and potentially violate regulations requiring timely payment and reporting, particularly if these regulations specify a shorter timeframe for industries dealing with pharmaceutical development and sales.",
                "contradicted_law": "Potential Violation of State/Federal Regulations Regarding Timely Payments and Reporting Standards",
                "location": "2.3"
            },
            {
                "type": "Inconsistencies - Legal Contradiction",
                "original_text": "During the term of this Agreement and for a period of five (5) years thereafter, the Parties each agree that Confidential Information of the disclosing party, which is disclosed to the recipient party pursuant to this Agreement: (i) shall be received and held in strict confidence, (ii) shall be used only for the purposes of this Agreement, and (iii) will not be disclosed by the recipient party (except as required by law, court order or regulation), its agents or employees without the prior written consent of the disclosing party",
                "changed_text": "During the term of this Agreement and for a period of one (1) year thereafter, the Parties each agree that Confidential Information of the disclosing party, which is disclosed to the recipient party pursuant to this Agreement: (i) shall be received and held in strict confidence, (ii) shall be used only for the purposes of this Agreement, and (iii) will not be disclosed by the recipient party (except as required by law, court order or regulation), its agents or employees without the prior written consent of the disclosing party",
                "explanation": "Reducing the confidentiality period to one year may be insufficient to protect trade secrets and other sensitive information, potentially violating legal standards for trade secret protection that often require a longer duration to maintain confidentiality and competitive advantage.",
                "contradicted_law": "State and Federal Trade Secret Laws (e.g., Defend Trade Secrets Act)",
                "location": "5.1"
            }
        ]
    }
]